Isleworth Healthcare Acquisition (ISLE) Stock Price, News & Analysis

Company Overview

Isleworth Healthcare Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to acquire a business in the biopharmaceutical or medical technology/device industries. The company was incorporated in 2020 and is based in Saint Petersburg, Florida.

Key Stats

• Today's Range: $10.01 to $10.02
• 50-Day Range: $9.96 to $10.14
• 52-Week Range: $9.70 to $10.14
• Volume: 301,893 shs
• Average Volume: 58,338 shs
• Market Capitalization: $262.17 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

ISLE Stock Analysis - Frequently Asked Questions

How were Isleworth Healthcare Acquisition's earnings last quarter?

Isleworth Healthcare Acquisition Corp. (NASDAQ:ISLE) posted its earnings results on Tuesday, August, 30th. The company reported $0.26 EPS for the quarter, missing analysts' consensus estimates of $0.30 by $0.04. The business's revenue for the quarter was down 2.5% on a year-over-year basis.

What other stocks do shareholders of Isleworth Healthcare Acquisition own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Isleworth Healthcare Acquisition investors own include Century Casinos (CNTY), Meta Platforms (META), Broadcom (AVGO), DDR (DDR), Eldorado Resorts (ERI), ImageWare Systems (IWSY) and Netflix (NFLX).

Company Calendar

• Last Earnings: 8/30/2016
• Today: 5/28/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: N/A
• Industry: Holding & Other Investment Offices
• Sub-Industry: Casinos & Gaming
• Current Symbol: NASDAQ:ISLE
• CIK: 863015
• Web: isleofcapricasinos.com
• Phone: 727-245-0146
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $4.84 million
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -217.53%
• Return on Assets: 5.05%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.59
• Quick Ratio: 0.59

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: $0.18 per share
• Price / Cash Flow: 54.15
• Book Value: ($0.29) per share
• Price / Book: -34.52

Miscellaneous

• Outstanding Shares: 26,191,000
• Free Float: 21,005,000
• Market Cap: $262.17 million
• Optionable: Not Optionable
• Beta: N/A